The tablet costs what the injection costs
Two product pages, one for the weekly injection and one for the oral tablet, print an identical entry rate and an identical six-month rate. The tablet page adds the words needle-free.
Twenty-seven of the one hundred and fifty-eight sellers here price an oral route at all, and most of those charge more for it. Pricing the two identically is a real editorial fact about this seller, and it is the reason to read it.
Both figures are starting-at rates. The six-month figure is the seller's own and is printed on the same card, so the commitment is at least visible with the discount.
The four numbers on the page that are not its prices
Both product pages carry a table headed as a comparison against competitors, with a row for this seller and rows for four named rival services, each with a monthly figure and a description of what it includes.
Those four figures belong to other companies. We have recorded none of them. This is the second seller in this batch whose page would have handed a careless scrape a set of competitors' prices as if they were its own, and it is the most common way a price comparison site publishes a lie about a company it has never read.
What is missing
A promotional banner offering a stated discount and free shipping rode both priced pages on the day they were read. Seventy-eight of the one hundred and fifty-eight sellers here carry a headline figure that is promotional, introductory, or conditioned on a commitment the number does not disclose.
No compounding pharmacy is named and no individual clinician is named. No service area is published; one hundred and fifteen of the one hundred and fifty-eight sellers here publish none. The membership question is not answered, though the seller uses the word membership to describe its own six-month rate in the comparison table, which is not the same thing.
Two different telephone numbers appear in the same footer block on two pages of the same site, which is a small thing and the kind of small thing worth noticing before relying on a contact route.
Ascend Vitality's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $199/mostarting at, per month; the same page states as low as $176/month on a 6-month plan | September 2026source |
| Semaglutide (compounded-oral) | $199/mostarting at, per month, for the needle-free tablet; the seller prices the tablet and the injection identically, and states as low as $176/month on a 6-month plan for both | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Ascend Vitality's current price →Good fit if
- Readers choosing between a daily tablet and a weekly injection who want to see them priced identically.
- Buyers who want a six-month rate printed beside the entry rate.
Look elsewhere if
- Anyone reading the comparison table as this seller's pricing; four of its figures belong to other companies.
- Readers who need a service-area list, a named pharmacy, or a named clinician.
- Buyers who want the membership question answered.
- People who want a price that is not sitting under a promotional banner.
How this review was verified
- Re-read both product pages on 6 September 2026, comparing the requested path to the effective path on each and running a nonsense path against the host in the same run.
- Recorded only this seller's own figures and excluded the four competitor figures printed beside them in its comparison table.
- Confirmed that the injection page and the tablet page print the same two figures, rather than assuming a single price applies to both routes.
- Recorded the promotional banner as a condition on the published figure rather than as a price.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.